HIGHLIGHTS
- who: Methods, and Respiratory Chain, Dysfunction from the Children`s Hospital ofUniversity of Philadelphia, Philadelphia, Pennsylvania, USA have published the paper: on international patent application PCT/US19/39631 based on US serial no, in the Journal: (JOURNAL) of July/20,/2022
- what: In contrast, the homozygous Fbxl4-/- zebrafish and C. elegans models used in the study had high survival rates, allowing for multiple long-term physiological studies.
SUMMARY
F-box and leucine-rich repeat protein 4 (FBXL4) mitochondrial disease is an autosomal recessive disorder that manifests with a highly variable breadth . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.